Document is current
Any future updates will be listed below
-
Authors
Bruni, Emanuele
Scaglione, Giovanni Luca
Tampone, Denise
Primerano, Alessia
Bartolini, Barbara
Tenoglio, Carlo Alessio
Di Campli, Cristiana
Collina, Maria Chiara
Odorisio, Teresa
Failla, Cristina Maria
-
Funding
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente RC2021-2024, Ricerca Corrente RC2021-2024)
- License Information
-
More Information
Article History
Received: 8 June 2024
Accepted: 28 October 2024
First Online: 12 November 2024
Declarations
:
: Carlo Alessio Tenoglio is the legal representative of Blufarma S.r.l., the producer of the FluorexinTM galenic product used in clinical practice for diabetic ulcer treatment. All other authors declare no competing interests.
